3D printed
drugs are developed by using powder-liquid three dimensional (3DP) printing
technologies. This technique uses an aqueous fluid which is able to bind
different or similar layer of powders and produces multiple type of products.
Drugs or Pills made by powder-liquid three dimensional techniques are
comparatively more soluble than other drugs or pills. Additionally, 3D printed
drugs are able to dissolve insoluble compounds such as silver chloride very
easily. Moreover, 3D printed high dose drugs can be dissolve within few seconds
that makes 3D printed drugs more acceptable. Moreover, 3D printed drugs are
comparatively reliable pills in very right dosages.
Market Size & Forecast
Global 3D
printed drugs market is anticipated to flourish over the forecast period i.e.
2017-2024. Rising health diseases across the globe and rising demand for
cheaper drugs or pills are some of the major factors which are likely to
bolster the growth of global 3D printed drugs market
during the forecast period.
In terms
of region, global 3D printed drugs market is segmented into five major regions
including North America, Europe, Asia Pacific, Latin America and Middle East
& Africa region. Among these regions, North America is expected to dominate
the global market of 3D printed drugs owing to factors such as rising number of
chronic diseases and growing adoption of technological advancements and
increasing geriatric population in this region.
For Sample Pages
please go through link below: http://www.researchnester.com/sample-request/2/rep-id-421
Additionally,
Asia Pacific region is expected to be fastest growing market for 3D printed
drugs during the forecast period. Factors such as rapid development of
healthcare infrastructure and increasing investment in research and development
of healthcare sector are envisioned to bolster the growth of 3D printed drugs
market in this region.
Moreover,
Europe region is expected to witness satisfactory growth over the forecast
period. This growth of 3D printed drugs market in this region can be attributed
to factors such as growing health consciousness among people of this region.
Market Segmentation
Our-in
depth analysis of the global 3D printed drugs market includes the following
segments:
By End User
Hospitals
Clinics
Research
Laboratories
By Region
Global 3D
printed drugs market is further classified on the basis of region as follows:
North
America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity
Analysis
Latin
America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth &
Opportunity Analysis
Europe
(U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands &
Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity
Analysis
Asia-Pacific
(China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market
size, Y-O-Y growth & Opportunity Analysis.
Middle
East and Africa (GCC, North Africa, South Africa and Rest of Middle East and
Africa) Market size, Y-O-Y growth & Opportunity Analysis
Growth Drivers & Challenges
Growth of
global 3D printed drugs market was initially driven by factors such as rising
health related diseases and growing geriatric population all across the globe.
Further, advantages of 3D printed drugs over general drugs such as low cost and
better solubility are making 3D printed drugs more acceptable for patients from
all over the world. Moreover, these advantages of 3D printed drugs are expected
to drive the growth of global 3D printed drugs market.
3D printed
drugs are better solution for those patients who respond to the same drugs or
pills in different way. Moreover, 3D printed drugs allow doctors or pharmacist
to use every patient’s individual information such as age and type of diseases
and give them precise medication dose accordingly. Such benefits of 3D printed
drugs are envisioned to drive the growth of 3D printed drugs market.
Request
For TOC Here: http://www.researchnester.com/toc-request/1/rep-id-421
Technological
advancement in healthcare sector is also a major factor which is anticipated to
bolster the demand for 3D printed drugs in near future. 3D printed drugs can be
produced with precise amount of dose according to the requirement of patients.
Furthermore, 3D printed drugs can perform multiple treatments with a single
pill. Such functions of 3D printed drugs are expected to drive the growth of
global 3D printed drugs market.
However,
lack of approval of 3D printed drugs in many countries is a major factor which
may restrict the production of such drugs in future. Additionally, lack of user
instruction and need for right packaging are some of the major challenges which
are projected to dampen the growth of global 3D printed drugs market.
Key Players
The major
players for 3D printed drugs market are as follows:
Aprecia
Company
Overview
Key
Product Offerings
Business
Strategy
SWOT
Analysis
Financial
Key
potential companies that may enter into manufacturing of 3D printed drugs are
mentioned below:
Extend
Biosciences
Bioduro
Affinity
Therapeutics
Osmotica
Pharmaceuticals
Acrux
Thiomatrix
Ico
Therapeutics Inc.
Formac
Pharmaceuticals
BiopharmX
Pacira
Pharmaceuticals Inc.
Scope
& Context
Overview
of the Parent Market
Analyst
View
Segmentation
The global
3D printed drugs market is segmented as follows:
By End
User Market Size & Y-O-Y Growth Analysis
By Region
Market Size & Y-O-Y Growth Analysis
Market
Dynamics
Supply
& Demand Risk
Competitive
Landscape
Porter’s
Five Force Model
Geographical
Economic Activity
Key
Players (respective SWOT Analysis) and their Strategies and Product Portfolio
Recent
Trends and Developments
Industry
Growth Drivers and Challenges
To know
more about this research, kindly visit: http://www.researchnester.com/reports/3d-printed-drugs-market-global-demand-analysis-opportunity-outlook-2024/421
For Table of Content &
Free Sample Report Contact:
Ajay
Daniel
Email:
ajay.daniel@researchnester.com
U.S. +1 646 586 9123
U.K. +44 203 608 5919
No comments:
Post a Comment